{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:09:20Z","timestamp":1747454960961,"version":"3.40.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03804-x","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T11:20:14Z","timestamp":1733397614000},"page":"2494-2501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-2870","authenticated-orcid":false,"given":"Dina","family":"Najjari-Jamal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angels","family":"Rovirosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gimeno-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Majercakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"De la Fuente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Mic\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Matute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"3804_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ygyno.2023.10.016","volume":"179","author":"P Critelli","year":"2023","unstructured":"Critelli P, et al. Outcomes and toxicity in re-irradiation of gynecologic cancer: Systematic review of the Italian association of radiation and clinical oncology (AIRO). Gynecol Oncol. 2023;179:33\u201341. https:\/\/doi.org\/10.1016\/j.ygyno.2023.10.016.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3804_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ygyno.2018.08.029","volume":"151","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Chang JS, Koom WS, Lee KC, Kim GE, Kim YB. Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer. Gynecol Oncol. 2018;151(2):208\u201314. https:\/\/doi.org\/10.1016\/j.ygyno.2018.08.029.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3804_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brachy.2019.11.008","volume":"19","author":"A Sturdza","year":"2020","unstructured":"Sturdza A, et al. American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers. Brachytherapy. 2020;19(2):127\u201338. https:\/\/doi.org\/10.1016\/j.brachy.2019.11.008.","journal-title":"Brachytherapy"},{"key":"3804_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061226","author":"S Bockel","year":"2021","unstructured":"Bockel S, et al. Systematic review image-guided brachytherapy for salvage reirradiation: a systematic review. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13061226.","journal-title":"Cancers"},{"issue":"10","key":"3804_CR5","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","volume":"23","author":"N Andratschke","year":"2022","unstructured":"Andratschke N, et al. European Society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol. 2022;23(10):e469\u201378. https:\/\/doi.org\/10.1016\/S1470-2045(22)00447-8.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3804_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/IGC.0000000000000028","volume":"24","author":"S Mabuchi","year":"2014","unstructured":"Mabuchi S, et al. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience. Int J Gynecol Cancer. 2014;24(1):141\u20138. https:\/\/doi.org\/10.1097\/IGC.0000000000000028.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"3804_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ygyno.2013.10.018","volume":"132","author":"A Zolciak-Siwinska","year":"2014","unstructured":"Zolciak-Siwinska A, et al. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk. Gynecol Oncol. 2014;132(1):93\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.018.","journal-title":"Gynecol Oncol"},{"key":"3804_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-1469-8","author":"E Leung","year":"2020","unstructured":"Leung E, et al. Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy. Radiat Oncol. 2020. https:\/\/doi.org\/10.1186\/s13014-020-1469-8.","journal-title":"Radiat Oncol"},{"key":"3804_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.radonc.2021.09.010","volume":"164","author":"F Slevin","year":"2021","unstructured":"Slevin F, et al. An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation. Radiother Oncol. 2021;164:104\u201314. https:\/\/doi.org\/10.1016\/j.radonc.2021.09.010.","journal-title":"Radiother Oncol"},{"issue":"1","key":"3804_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12\u201339. https:\/\/doi.org\/10.1136\/ijgc-2020-002230.","journal-title":"Int J Gynecol Cancer"},{"key":"3804_CR11","doi-asserted-by":"publisher","first-page":"109947","DOI":"10.1016\/j.radonc.2023.109947","volume":"189","author":"J Willmann","year":"2023","unstructured":"Willmann J, et al. Re-irradiation in clinical practice: results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform. Radiother Oncol. 2023;189:109947. https:\/\/doi.org\/10.1016\/j.radonc.2023.109947.","journal-title":"Radiother Oncol"},{"issue":"3","key":"3804_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/PGP.0b013e31829c6757","volume":"33","author":"EJ Moschiano","year":"2014","unstructured":"Moschiano EJ, et al. Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites. Int J Gynecol Pathol. 2014;33(3):268\u201373. https:\/\/doi.org\/10.1097\/PGP.0b013e31829c6757.","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"3804_CR13","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.brachy.2017.07.007","volume":"16","author":"SC Kamran","year":"2017","unstructured":"Kamran SC, et al. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer. Brachytherapy. 2017;16(6):1159\u201368. https:\/\/doi.org\/10.1016\/j.brachy.2017.07.007.","journal-title":"Brachytherapy"},{"issue":"16","key":"3804_CR14","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1158\/0008-5472.CAN-15-3451","volume":"76","author":"M Hettich","year":"2016","unstructured":"Hettich M, Lahoti J, Prasad S, Niedermann G. Checkpoint antibodies but not T cell-recruiting diabodies effectively synergize with TIL-inducing \u03b3-irradiation. Cancer Res. 2016;76(16):4673\u201383. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3451.","journal-title":"Cancer Res"},{"issue":"5","key":"3804_CR15","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.21037\/tcr-20-3019","volume":"10","author":"C Ladbury","year":"2021","unstructured":"Ladbury C, et al. Combination radiation and immunotherapy in gynecologic malignancies\u2014a comprehensive review. Transl Cancer Res. 2021;10(5):2609\u201319. https:\/\/doi.org\/10.21037\/tcr-20-3019.","journal-title":"Transl Cancer Res"},{"issue":"2","key":"3804_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00262-022-03253-x","volume":"72","author":"EA De Jaeghere","year":"2023","unstructured":"De Jaeghere EA, et al. Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: results of the phase II PRIMMO study. Cancer Immunol Immunother. 2023;72(2):475\u201391. https:\/\/doi.org\/10.1007\/s00262-022-03253-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"10185","key":"3804_CR17","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(18)32487-5.","journal-title":"Lancet"},{"issue":"2","key":"3804_CR18","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1111\/ajco.12185","volume":"12","author":"Y Seo","year":"2016","unstructured":"Seo Y, et al. Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: feasibility and complication. Asia Pac J Clin Oncol. 2016;12(2):e280\u20138. https:\/\/doi.org\/10.1111\/ajco.12185.","journal-title":"Asia Pac J Clin Oncol"},{"key":"3804_CR19","doi-asserted-by":"publisher","unstructured":"Hasan S, et al. Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and paraaortic region treated with stereotactic body radiation therapy. Front Oncol. 2016;22(6):249. https:\/\/doi.org\/10.3389\/fonc.2016.00249.","DOI":"10.3389\/fonc.2016.00249"},{"issue":"6","key":"3804_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.prro.2019.05.012","volume":"9","author":"DC Ling","year":"2019","unstructured":"Ling DC, Vargo JA, Burton SA, Heron DE, Beriwal S. Salvage curative-intent reirradiation stereotactic body radiation therapy for isolated pelvic and\/or paraortic recurrences of gynecologic malignancies. Pract Radiat Oncol. 2019;9(6):418\u201325. https:\/\/doi.org\/10.1016\/j.prro.2019.05.012.","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"3804_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clon.2022.09.047","volume":"35","author":"R Muirhead","year":"2023","unstructured":"Muirhead R, Dean C, D\u00edez P, Williams M, McDonald F. Launch of the UK SABR consortium pelvic stereotactic ablative radiotherapy re-irradiation guidelines and national audit. Clin Oncol (R Coll Radiol). 2023;35(1):29\u201332. https:\/\/doi.org\/10.1016\/j.clon.2022.09.047.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"3804_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13014-017-0926-5","volume":"12","author":"N Arians","year":"2017","unstructured":"Arians N, et al. Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial. Radiat Oncol. 2017;12(1):188. https:\/\/doi.org\/10.1186\/s13014-017-0926-5.","journal-title":"Radiat Oncol"},{"issue":"1","key":"3804_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13014-023-02198-4","volume":"18","author":"E Meixner","year":"2023","unstructured":"Meixner E, et al. Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial. Radiat Oncol. 2023;18(1):5. https:\/\/doi.org\/10.1186\/s13014-023-02198-4.","journal-title":"Radiat Oncol"},{"issue":"3","key":"3804_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semradonc.2020.02.007","volume":"30","author":"CB Simone","year":"2020","unstructured":"Simone CB, et al. Proton reirradiation: expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies. Semin Radiat Oncol. 2020;30(3):253\u201361. https:\/\/doi.org\/10.1016\/j.semradonc.2020.02.007.","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"3804_CR25","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/j.ijrobp.2020.07.1576","volume":"108","author":"P Mohindra","year":"2020","unstructured":"Mohindra P, et al. Clinical practice patterns for proton therapy in gynecological cancers: report from a prospective multi-institutional registry. Int J Radiat Oncol Biol Phys. 2020;108(3):e498\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.07.1576.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03804-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T14:17:16Z","timestamp":1747405036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03804-x","relation":{},"ISSN":["1699-3055"],"issn-type":[{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors agree to submit the manuscript to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}